Novartis Ag NVS
NYSE NVS
$143.15 -2.56 (-1.76%)
As of: Sep 30, 2026 · 3:39 PM EDT

Novartis Ag (NVS) Total Liabilities (2009 - 2026)

Updated

Novartis Ag (NVS) recorded Total Liabilities of $80.09 billion in Q2 2026, up 28.5% from $62.34 billion a year earlier and up 0.6% from the prior quarter.

Analysis

Novartis Ag (NVS) Total Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Novartis Ag reported Total Liabilities of $64.4 billion, up 10.8% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
  • Across earlier years, Total Liabilities came in at $58.12 billion in FY2024 (+9.3%), $53.2 billion in FY2023 (-8.3%), $58.03 billion in FY2022 (-9.3%) and $63.97 billion in FY2021 (-10.0%).
  • The Q2 2026 figure is the highest quarterly Total Liabilities since Q1 2019.
  • On a year-over-year basis, Total Liabilities has increased for seven consecutive quarters, with growth averaging 10.9% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 29.5% in Q1 2026, against a decline of 19.3% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $79.61 billion (Q1 2026), $64.4 billion (Q4 2025) and $62.54 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 116.09 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 141.05 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 65.46 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 7.18 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 65.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.09 Bn
Mar 31, 2026 79.61 Bn
Dec 31, 2025 64.40 Bn
Sep 30, 2025 62.54 Bn
Jun 30, 2025 62.34 Bn
Mar 31, 2025 61.49 Bn
Dec 31, 2024 58.12 Bn
Sep 30, 2024 60.08 Bn
Jun 30, 2024 55.60 Bn
Mar 31, 2024 54.58 Bn
Dec 31, 2023 53.20 Bn
Sep 30, 2023 74.45 Bn
Jun 30, 2023 59.05 Bn
Mar 31, 2023 60.10 Bn
Dec 31, 2022 58.03 Bn
Sep 30, 2022 57.57 Bn
Jun 30, 2022 59.90 Bn
Mar 31, 2022 63.51 Bn
Dec 31, 2021 63.97 Bn
Sep 30, 2021 64.27 Bn
API Access

Novartis Ag Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NVS&period=max&api_key=YOUR_API_KEY